Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shern L Chew

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
European Radiology|August 4, 2004
CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas)Anju Sahdev, A Sohaib, John P Monson, et al.
Human Molecular Genetics|July 11, 2006
An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancersPhilip J Smith, Chaolin Zhang, Jinhua Wang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 17, 2009
A single-center open-label study to investigate the efficacy and safety of repeated subcutaneous injections of lanreotide Autogel in patients with acromegaly previously treated with octreotidePhillip Kelly, Kathy T Maher, Shern L Chew, et al.
Molecular Endocrinology (Baltimore, Md.)|July 12, 2007
Pre-spliceosomal binding of U1 small nuclear ribonucleoprotein (RNP) and heterogenous nuclear RNP E1 is associated with suppression of a growth hormone receptor pseudoexonScott A Akker, Shivani Misra, Shazad Aslam, et al.
European Journal of Endocrinology|April 23, 2009
Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumorsMichel Procopiou, Hazel Finney, Scott A Akker, et al.
Endocrinology|December 26, 2001
An exonic splicing enhancer in human IGF-I pre-mRNA mediates recognition of alternative exon 5 by the serine-arginine protein splicing factor-2/alternative splicing factorPhilip J Smith, Emma L Spurrell, John Coakley, et al.
Clinical Endocrinology|January 5, 2007
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patientsAmar Agha, Dorothy Walker, Les Perry, et al.
Molecular and Cellular Endocrinology|March 20, 2003
ACTH and alpha-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathwayDennis Norman, Andrea M Isidori, Vanni Frajese, et al.
European Journal of Endocrinology|March 10, 2010
Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECTTara Barwick, Iain Murray, Hakim Megadmi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndromeAndrea M Isidori, Gregory A Kaltsas, Shahid Mohammed, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
European Radiology|August 4, 2004
CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas)Anju Sahdev, A Sohaib, John P Monson, et al.
Human Molecular Genetics|July 11, 2006
An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancersPhilip J Smith, Chaolin Zhang, Jinhua Wang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 17, 2009
A single-center open-label study to investigate the efficacy and safety of repeated subcutaneous injections of lanreotide Autogel in patients with acromegaly previously treated with octreotidePhillip Kelly, Kathy T Maher, Shern L Chew, et al.
Molecular Endocrinology (Baltimore, Md.)|July 12, 2007
Pre-spliceosomal binding of U1 small nuclear ribonucleoprotein (RNP) and heterogenous nuclear RNP E1 is associated with suppression of a growth hormone receptor pseudoexonScott A Akker, Shivani Misra, Shazad Aslam, et al.
European Journal of Endocrinology|April 23, 2009
Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumorsMichel Procopiou, Hazel Finney, Scott A Akker, et al.
Endocrinology|December 26, 2001
An exonic splicing enhancer in human IGF-I pre-mRNA mediates recognition of alternative exon 5 by the serine-arginine protein splicing factor-2/alternative splicing factorPhilip J Smith, Emma L Spurrell, John Coakley, et al.
Clinical Endocrinology|January 5, 2007
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patientsAmar Agha, Dorothy Walker, Les Perry, et al.
Molecular and Cellular Endocrinology|March 20, 2003
ACTH and alpha-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathwayDennis Norman, Andrea M Isidori, Vanni Frajese, et al.
European Journal of Endocrinology|March 10, 2010
Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECTTara Barwick, Iain Murray, Hakim Megadmi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndromeAndrea M Isidori, Gregory A Kaltsas, Shahid Mohammed, et al.
Pageof 4